Trefoil factor 3 expression in epithelial ovarian cancer exerts a minor effect on clinicopathological parameters.

Hoellen, Friederike; Kostara, Athina; Karn, Thomas; Holtrich, Uwe; El-Balat, Ahmed; Otto, Mike; Rody, Achim; Hanker, Lars C

Hoellen, Friederike; Kostara, Athina; Karn, Thomas; Holtrich, Uwe; El-Balat, Ahmed; Otto, Mike; Rody, Achim; Hanker, Lars C.

Afiliação

Hoellen F; Department of Gynecology and Obstetrics, University of Lübeck, D-23538 Lübeck, Germany.
Kostara A; Department of Gynecology and Obstetrics, University of Lübeck, D-23538 Lübeck, Germany.
Karn T; Department of Obstetrics and Gynecology, Goethe University, D-60323 Frankfurt, Germany.
Holtrich U; Department of Obstetrics and Gynecology, Goethe University, D-60323 Frankfurt, Germany.
El-Balat A; Department of Obstetrics and Gynecology, Goethe University, D-60323 Frankfurt, Germany.
Otto M; Medical Center for Histopathology, Cytology and Molecular Diagnostics, D-54296 Trier, Germany.
Rody A; Department of Gynecology and Obstetrics, University of Lübeck, D-23538 Lübeck, Germany.
Hanker LC; Department of Gynecology and Obstetrics, University of Lübeck, D-23538 Lübeck, Germany.

Mol Clin Oncol ; 5(4): 422-428, 2016 Oct.

Article em En | MEDLINE | ID: mdl-27699037

Palavras-chave

chemosensitivity; ovarian cancer; platinum; trefoil factor 3; trefoil factors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google